248 related articles for article (PubMed ID: 28250129)
21. Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration.
Campos SK; Chapman JA; Deymier MJ; Bronnimann MP; Ozbun MA
J Virol; 2012 Apr; 86(8):4169-81. PubMed ID: 22345461
[TBL] [Abstract][Full Text] [Related]
22. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
23. A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.
Cerqueira C; Pang YY; Day PM; Thompson CD; Buck CB; Lowy DR; Schiller JT
J Virol; 2016 Jan; 90(2):1096-107. PubMed ID: 26559838
[TBL] [Abstract][Full Text] [Related]
24. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y
J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785
[TBL] [Abstract][Full Text] [Related]
25. γ-Secretase promotes membrane insertion of the human papillomavirus L2 capsid protein during virus infection.
Inoue T; Zhang P; Zhang W; Goodner-Bingham K; Dupzyk A; DiMaio D; Tsai B
J Cell Biol; 2018 Oct; 217(10):3545-3559. PubMed ID: 30006461
[TBL] [Abstract][Full Text] [Related]
26. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.
Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK
J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus L2 Capsid Protein Stabilizes γ-Secretase during Viral Infection.
Crite M; DiMaio D
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458534
[TBL] [Abstract][Full Text] [Related]
28. Identification of the dynein light chains required for human papillomavirus infection.
Schneider MA; Spoden GA; Florin L; Lambert C
Cell Microbiol; 2011 Jan; 13(1):32-46. PubMed ID: 21166973
[TBL] [Abstract][Full Text] [Related]
29. p120 catenin recruits HPV to γ-secretase to promote virus infection.
Harwood MC; Dupzyk AJ; Inoue T; DiMaio D; Tsai B
PLoS Pathog; 2020 Oct; 16(10):e1008946. PubMed ID: 33085724
[TBL] [Abstract][Full Text] [Related]
30. Target cell cyclophilins facilitate human papillomavirus type 16 infection.
Bienkowska-Haba M; Patel HD; Sapp M
PLoS Pathog; 2009 Jul; 5(7):e1000524. PubMed ID: 19629175
[TBL] [Abstract][Full Text] [Related]
31. Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.
DiGiuseppe S; Bienkowska-Haba M; Guion LGM; Keiffer TR; Sapp M
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566382
[TBL] [Abstract][Full Text] [Related]
32. Arrangement of L2 within the papillomavirus capsid.
Buck CB; Cheng N; Thompson CD; Lowy DR; Steven AC; Schiller JT; Trus BL
J Virol; 2008 Jun; 82(11):5190-7. PubMed ID: 18367526
[TBL] [Abstract][Full Text] [Related]
33. Cell-Penetrating Peptide Mediates Intracellular Membrane Passage of Human Papillomavirus L2 Protein to Trigger Retrograde Trafficking.
Zhang P; Monteiro da Silva G; Deatherage C; Burd C; DiMaio D
Cell; 2018 Sep; 174(6):1465-1476.e13. PubMed ID: 30122350
[TBL] [Abstract][Full Text] [Related]
34. Characterizing the spatio-temporal role of sorting nexin 17 in human papillomavirus trafficking.
Bergant M; Peternel Š; Pim D; Broniarczyk J; Banks L
J Gen Virol; 2017 Apr; 98(4):715-725. PubMed ID: 28475030
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.
Siddiqa A; Massimi P; Pim D; Broniarczyk J; Banks L
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321327
[TBL] [Abstract][Full Text] [Related]
36. HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer.
Namvar A; Bolhassani A; Hashemi M
Bratisl Lek Listy; 2016; 117(3):179-84. PubMed ID: 26925750
[TBL] [Abstract][Full Text] [Related]
37. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
38. Modification of human papillomavirus minor capsid protein L2 by sumoylation.
Marusic MB; Mencin N; Licen M; Banks L; Grm HS
J Virol; 2010 Nov; 84(21):11585-9. PubMed ID: 20739540
[TBL] [Abstract][Full Text] [Related]
39. Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.
Richards KF; Bienkowska-Haba M; Dasgupta J; Chen XS; Sapp M
J Virol; 2013 Nov; 87(21):11426-37. PubMed ID: 23966387
[TBL] [Abstract][Full Text] [Related]
40. The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.
Schneider MA; Scheffer KD; Bund T; Boukhallouk F; Lambert C; Cotarelo C; Pflugfelder GO; Florin L; Spoden GA
J Virol; 2013 Apr; 87(8):4461-74. PubMed ID: 23388722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
